Trial ID or NCT#

NCT02168764

Status

RECRUITING

Purpose

The primary objective of the study is to demonstrate the safety and efficacy of SPG stimulation with the ATI Neurostimulation System when used to treat acute cluster attacks in chronic cluster headache patients.

Official Title

Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache

Eligibility Criteria

Ages Eligible for Study: Older than 22 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Meredith Barad, MD
Headache and facial pain specialist, Pain management specialist
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine Clinical Associate Professor, Neurology & Neurological Sciences

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM